RxDoctor Payments Data

Marcie Nichols

Optometrist · Minneapolis, MNNPI 1235241993

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.5% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Alcon at 49.4% of the total. 2025 is the largest year on record at $1,882, 8.6 times the $220 reported in 2019. Among optometrist clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,964in general payments, 2019–2025

Across 78 payments — averaging $50.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$2K
  • Lumenis BE Inc$1K
  • Johnson & Johnson Vision Care, Inc.$401
  • Coopervision Inc.$212
  • Optos, Inc.$85
  • Novartis$32
  • plus $29 from 1 others

What the payments were for

  • Speaking & faculty fees$2206%
  • Food & beverage$3,74494%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,964 in reported general payments places this provider in the 95th percentile of 826 optometrist providers in Minnesota.

See all optometrist providers in Minnesota

Medicare billing

Part B allowed, 2024
$10,242
Medicare patients
49
Services billed
476

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost39$655
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat11$215

Paid to pharmacies, not to this prescriber.

Other optometrist in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →